跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 57,718 条关于
“Japan Early Light Medical Corporation”
全部
57,718
临床试验
28,074
药物
1,079
机构
2,960
资讯
25,605
8个月前
EUDA Health Launches Comprehensive Stem Cell Platform in China with National Clinical Network
去年
Journey Medical's Emrosi Receives FDA Approval for Rosacea Treatment
去年
SeaStar Medical Focuses on Hyperinflammation Therapies for Critical Illnesses
去年
FDA Approves Journey Medical's Emrosi™ for Rosacea Treatment
去年
Tofersen Receives Green Light in Japan for SOD1-Related ALS
去年
Journey Medical Corporation Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights
去年
FDA Approves Journey Medical's Emrosi™ for Rosacea Treatment
去年
Yuhan Corporation Receives $15 Million Milestone from Janssen Following Japan Launch of Lazertinib-Amivantamab Combination for EGFR-Mutated NSCLC
去年
Japan Introduces Expedited Approval Pathway for Infectious Disease Drugs
去年
CSPC Pharmaceutical Advances Hypertension and Obesity Treatments with Novel Drug Approvals
第 1 页，共 2561 页
上一页
下一页
